<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109358">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02032264</url>
  </required_header>
  <id_info>
    <org_study_id>RMA-2013-04</org_study_id>
    <nct_id>NCT02032264</nct_id>
  </id_info>
  <brief_title>Next Generation Sequencing Screening for Embryonic Ploidy Status</brief_title>
  <acronym>nexgen</acronym>
  <official_title>Evaluation of the Efficacy of Next Generation Sequencing in Predicting Embryonic Karyotype and Subsequent Pregnancy Outcomes in in Vitro Fertilization Cycles (IVF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive Medicine Associates of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Reproductive Medicine Associates of New Jersey</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the benefits of using next generation sequencing to assess embryonic aneuploidy.
       All viable blastocysts will be biopsied and cryopreserved for  future transfer.   After the
      final embryo is cryopreserved, patients will be randomized to either the intervention group
      or the control group. Patients and doctors are blinded to the randomization until study
      completion. A Double Embryo Transfer (DET) will be performed with either screened or
      unscreened embryos depending on randomization. A Single Embryo Transfer (SET) may occur in
      cases where only one embryo is available for transfer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Impact of next generation sequencing on the embryos produced from IVF on implantation rates</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To evaluate the benefits, if any, of using next generation sequencing based Comprehensive Chromosome Screening (CCS) in the selection of embryos for transfer during clinical IVF cycles</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delivery Rates</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Comprehensive Chromosome Screening</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Trophectoderm biopsy will be performed on all blastocysts and CCS via next generation sequencing screening performed on biopsy samples. Patients will proceed with a Double Embryo Transfer (DET) of the two morphologically best euploid embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Comprehensive Chromosome Screening</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The patients in this group will proceed with a Double Embryo Transfer (DET) of the two morphologically best embryos.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comprehensive Chromosome Screening</intervention_name>
    <description>On day 6 of embryo development, all embryos will undergo a trophectoderm biopsy using the standardized technique, as according to standard laboratory protocol and without regard to study. Comprehensive Chromosome Screening (CCS), will be performed via next generation sequencing and results will be available at the time of study completion.</description>
    <arm_group_label>Comprehensive Chromosome Screening</arm_group_label>
    <other_name>PGD</other_name>
    <other_name>CCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient undergoing IVF/CCS (no PGD banking)

          -  Patient meets ASRM guidelines for Double Embryo Transfer (DET)

          -  Donor Sperm OK

          -  AMH ≥ 1.2

          -  FSH ≤ 12

          -  BAFC ≥12

          -  Max 1 prior failed IVF cycle for patients 35-45 years old

          -  Patient &lt;35 years old MUST have 1 prior failed IVF cycle

        Exclusion Criteria:

          -  Chronic endometrial insufficiency

          -  Use of oocyte donor or gestational carriers

          -  Medical contraindications to Double Embryo Transfer (DET)

          -  Male Factor (&lt;100,000 sperm or surgical sperm)

          -  Communicating hydrosalpinx (on HSG)

          -  Single gene disorders or sex selection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard T Scott, M.D., HCLD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive Medicine Associates of New Jersey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine V Reda, BSN, RN</last_name>
    <phone>973-656-2841</phone>
    <email>clinicalresearchteam@rmanj.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janine M Casciello, BA</last_name>
    <phone>973-656-2841</phone>
    <email>clinicalresearchteam@rmanj.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reproductive Medicine Associates of New Jersey</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine V Reda, BSN, RN</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@rmanj.com</email>
    </contact>
    <contact_backup>
      <last_name>Janine M Casciello, BA</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@rmanj.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard T Scott, M.D., HCLD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.rmanj.com/</url>
    <description>Reproductive Medicine Associates of New Jersey</description>
  </link>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 9, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Next generation sequencing</keyword>
  <keyword>Embryonic aneuploidy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
